Jan, 2 2026, 0 Comments
Metabolic-Associated Fatty Liver: How Weight Loss and GLP-1 Drugs Work Together
MASLD is a common liver condition linked to obesity and insulin resistance. Losing 10% of body weight can reverse liver damage, and GLP-1 drugs like semaglutide help achieve this by reducing appetite and fat buildup. Together, they offer real hope for recovery.
Read More